-
Doxorubicin and Persister-Cell Ferroptosis
2026-09-02
Doxorubicin, also known as Adriamycin, is more than a DNA-damaging reference compound. This article explains how to use its treatment pressure to investigate reversible persister states, lipid remodeling, mitochondrial dependence, and ferroptosis sensitivity in cancer models.
-
Taltirelin acetate: Reliable Assay Workflows
2026-09-02
A scenario-based guide to using Taltirelin acetate in neuronal viability, neuroprotection, formulation, and translational research workflows. It explains how SKU C8755 can support controlled dosing, practical stock preparation, and more defensible interpretation of assay results.
-
Flubendazole Workflows for Autophagy Research
2026-09-02
Flubendazole supports controlled autophagy modulation research when formulation, exposure time, and cell-killing readouts are planned together. This workflow translates evidence from cancer-response research into practical assay design, helping distinguish growth arrest from true cytotoxicity.
-
GSK2606414 in PERK-Driven Disc Inflammation
2026-09-01
Explore how GSK2606414, a selective PERK inhibitor, can be used to test the PERK/eIF2α/ATF4–JAK1–STAT3 mechanism linking ER stress to nucleus pulposus cell pyroptosis. This article translates recent mechanistic findings into a rigorous assay and interpretation framework.
-
Dihydroartemisinin: Reproducible Assay Workflows
2026-08-31
This scenario-driven guide shows how Dihydroartemisinin, SKU N1713, can improve compound handling and interpretation in cell viability, proliferation, mTOR, and malaria-related workflows. It combines product-backed solubility, purity, storage, and analytical information with practical controls for more defensible experiments.
-
Nuclear mTORC1 Revealed by TerminaTOR
2026-08-31
The reference study introduces TerminaTOR, a genetically encodable inhibitor that selectively perturbs mTORC1 at defined subcellular locations. By comparing lysosomal and nuclear targeting, the authors show that nuclear mTORC1 regulates transcription of CCAAT motif-containing genes, revealing functional spatial compartmentalization that global inhibitors cannot resolve.
-
DrPISA Expands Thermal Proteomics to Insoluble Targets
2026-08-30
The DrPISA study introduces a deep eutectic solvent-assisted reverse PISA workflow that measures heat-aggregated proteins often missed by soluble-protein thermal profiling. Its DES-48 formulation improved proteome recovery, enabled detection of subtle stability changes, reduced mass-spectrometry demands, and revealed LULL1 as a previously under-recognized celastrol-associated protein.
-
Ridaforolimus: A Senolytic Discovery Framework
2026-08-29
Ridaforolimus, also called Deforolimus or MK-8669, offers a precise way to interrogate mTOR-dependent growth and survival programs. This article connects its cancer biology to machine-learning-guided senolytic discovery while clarifying how to distinguish pathway suppression, apoptosis, and true senolytic activity.
-
Trametinib: A MEK–TERT Assay Framework
2026-08-28
Trametinib (GSK1120212) is more than a potent MEK1/2 inhibitor: it can serve as a controlled perturbation for connecting MAPK signaling, cell-cycle arrest, and telomerase biology. This article translates APEX2–TERT findings into practical assay decisions without overstating an unproven direct drug mechanism.
-
Esflurbiprofen and SERT–nNOS in Rapid Antidepressant Action
2026-08-28
The reference study identifies esflurbiprofen as a candidate fast-onset antidepressant by disrupting the serotonin transporter–neuronal nitric oxide synthase interaction in the dorsal raphe nucleus. Its combination of mBRET-based interaction screening, stress-model behavioral analysis, molecular assays, and resting-state fMRI connects a protein-complex mechanism with serotonergic circuit and behavioral changes in mice.
-
Cy5-UTP for Spatial RNA Trafficking Assays
2026-08-28
Cy5-UTP enables direct, spectrally defined RNA probe synthesis for FISH and neuronal RNA-trafficking studies. This article explains how to translate axonal transport findings into rigorous fluorescence assay design while separating probe signal from biological interpretation.
-
TMRE Assay Kit: Reading ΔΨm in Na+ Stress
2026-08-27
The TMRE mitochondrial membrane potential assay kit turns ΔΨm into a practical readout of mitochondrial injury, with special relevance to sodium-driven energy failure. This article connects TMRE interpretation, CCCP validation, and experimental design to the mechanism of NECSO described in recent Nature Communications research.
-
AMPK’s Dual Role in Autophagy Under Energy Stress
2026-08-26
The reference study challenges the prevailing view that AMPK uniformly activates autophagy during glucose deprivation. Using direct measurements of ULK1 activity and autophagy-initiation signaling, the authors show that AMPK suppresses autophagy during acute energy crisis while preserving the ULK1-associated machinery needed for recovery.
-
AG-221 (Enasidenib) Workflow for IDH2 AML
2026-08-26
AG-221 and Enasidenib provide a practical pharmacological handle for testing mutant-IDH2 biology, 2-hydroxyglutarate reduction, and leukemia cell differentiation in controlled AML models. This workflow extends beyond viability by connecting oncometabolite suppression to CD44-dependent metabolic rewiring, resistance, and combination hypotheses.
-
Pyridostatin: From G-Quadruplexes to Translation
2026-08-26
Pyridostatin TFA offers translational researchers a practical chemical entry point into G-quadruplex biology. This article connects its established role in telomere dysfunction and cancer models with emerging evidence that RNA G-quadruplexes influence TDP-43 condensation and toxicity, while defining the experimental boundaries that must be respected before moving toward therapeutic claims.